Role of basiliximab in the prevention of acute cellular rejection in adult to adult living-related liver transplantation: a single center experience

We report our single center experience with the use of basiliximab, a chimeric monoclonal antibody directed against the alpha chain of the interleukin-2 (IL-2) receptor (CD25), in combination with a steroid- and tacrolimus-based regimen in adult to adult living-related liver transplantation (ALRLT)....

Descripción completa

Detalles Bibliográficos
Autores principales: Gruttadauria, S, Mandalà, L, Biondo, D, Spampinato, M, Lamonaca, V, Volpes, R, Vizzini, G, Marsh, JW, Marcos, A, Gridelli, B
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2007
Materias:
Case Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721340/
https://www.ncbi.nlm.nih.gov/pubmed/19707350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721340/
https://www.ncbi.nlm.nih.gov/pubmed/19707350

Ejemplares similares